RAPP - Rapport Therapeutics Inc.
IEX Last Trade
21.86
2.060 9.424%
Share volume: 108,481
Last Updated: Fri 30 Aug 2024 09:59:01 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$19.80
2.06
10.40%
View ratios
| Fiscal Date | |
|---|---|
| Fiscal Quarter | |
| Report Date | |
| Assets | |
| Total Assets | |
| Current Assets | |
| Inventories | |
| Other Current Assets | |
| Short Term Investments | |
| Total Receivables | |
| Current Cash | |
| Total Non-current Assets | |
| Property Plant Equipment | |
| Other Assets | |
| Intangible Assets | |
| Goodwill | |
| Liabilities and shareholders’ equity | |
| Total Liabilities and shareholders’ equity | |
| Total liabilities | |
| Total current liabilities | |
| Accounts Payable | |
| Other liabilities | |
| Current long term debt | |
| Long term debt | |
| Other liabilities | |
| Minority interest | |
| Total Shareholder equity | |
| Common stock | |
| Retained earnings |